Subcutaneous bortezomib for treatment of TEMPI syndrome

Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):e221-3. doi: 10.1016/j.clml.2014.07.004. Epub 2014 Jul 15.

Authors

Sina Jasim¹, Gibran Mahmud², Bahar Bastani³, Mark Fesler²

Affiliations

¹ Department of Medicine, Saint Louis University, St. Louis, MO.
² Division of Hematology-Oncology, Saint Louis University, St. Louis, MO.
³ Division of Nephrology, Saint Louis University, St. Louis, MO. Electronic address: [email protected].

PMID: 25172534
DOI: 10.1016/j.clml.2014.07.004

No abstract available

Keywords: Monoclonal gammopathy; Neuropathy; Perinephric cysts; Polycythemia; Telangiectasia.

Publication types

Case Reports

MeSH terms

Boronic Acids / administration & dosage*
Bortezomib
Edema / diagnosis
Edema / drug therapy*
Female
Humans
Middle Aged
Paraproteinemias / diagnosis
Paraproteinemias / drug therapy*
Polycythemia / diagnosis
Polycythemia / drug therapy*
Proteasome Inhibitors / administration & dosage*
Pyrazines / administration & dosage*
Skin / pathology
Telangiectasis / diagnosis
Telangiectasis / drug therapy*
Treatment Outcome

Substances

Boronic Acids
Proteasome Inhibitors
Pyrazines
Bortezomib